1 |
Huang J, Fu X, Chen X, Li Z, Huang Y, Liang C. Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis. Front Immunol 2021;12:686155. [PMID: 34305919 DOI: 10.3389/fimmu.2021.686155] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
2 |
Cai Y, Yu R, Kong Y, Feng Z, Xu Q. METTL3 regulates LPS-induced inflammatory response via the NOD1 signaling pathway. Cell Signal 2022;:110283. [PMID: 35176453 DOI: 10.1016/j.cellsig.2022.110283] [Reference Citation Analysis]
|
3 |
Liu L, Li H, Hu D, Wang Y, Shao W, Zhong J, Yang S, Liu J, Zhang J. Insights into N6-methyladenosine and programmed cell death in cancer. Mol Cancer 2022;21:32. [PMID: 35090469 DOI: 10.1186/s12943-022-01508-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
|
4 |
Shen L, Yu Y, Jiang M, Zhao J. Alteration of the m6A methylation landscape in a mouse model of scleroderma. Epigenomics 2021;13:1867-83. [PMID: 34791892 DOI: 10.2217/epi-2021-0369] [Reference Citation Analysis]
|
5 |
Lin X, Tao C, Zhang R, Zhang M, Wang Q, Chen J. N6-methyladenosine modification of TGM2 mRNA contributes to the inhibitory activity of sarsasapogenin in rheumatoid arthritis fibroblast-like synoviocytes. Phytomedicine 2021;95:153871. [PMID: 34902811 DOI: 10.1016/j.phymed.2021.153871] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
6 |
Chen Q, Li H, Liu Y, Zhao M. Epigenetic Regulation of Immune and Inflammatory Responses in Rheumatoid Arthritis. Front Immunol 2022;13:881191. [DOI: 10.3389/fimmu.2022.881191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
7 |
Yang C, Dong Z, Ling Z, Chen Y. The crucial mechanism and therapeutic implication of RNA methylation in bone pathophysiology. Ageing Res Rev 2022;79:101641. [PMID: 35569786 DOI: 10.1016/j.arr.2022.101641] [Reference Citation Analysis]
|